Literature DB >> 8082617

Likelihood of pregnancy in individuals with idiopathic/cryptogenic epilepsy: social and biologic influences.

N Schupf1, R Ottman.   

Abstract

We interviewed 1,558 adults with idiopathic/cryptogenic epilepsy ascertained from voluntary organizations and 316 of their siblings without epilepsy to determine their personal history of marriage and pregnancy. We examined the effects of seizure type, age at onset, and family history of epilepsy on the sex-specific likelihood of pregnancy in individuals with idiopathic/cryptogenic epilepsy as compared with their same-sex siblings. Overall, men with idiopathic/cryptogenic epilepsy were only 36% as likely as male unaffected siblings ever to have fathered a pregnancy. In men, the reduced likelihood of fathering a pregnancy was associated with partial-onset seizures, early age at onset (< 20 years), and a negative family history of epilepsy, and the effects of these epilepsy characteristics appeared to be mediated through reduced marriage rates. Among men with epilepsy who had ever been married, reproductive disadvantage was confined to those with early-onset (< 10 years) partial epilepsy. Overall, women with idiopathic/cryptogenic epilepsy were only 37% as likely ever to have had a pregnancy as female unaffected siblings; this effect was not strongly influenced by seizure type, age at onset, or family history of epilepsy. In women who had ever been married, unlike in men, reduced likelihood of pregnancy persisted, regardless of seizure type, age at onset, or family history of epilepsy.

Entities:  

Mesh:

Year:  1994        PMID: 8082617     DOI: 10.1111/j.1528-1157.1994.tb02506.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  10 in total

1.  Low fertility in men with epilepsy: unhappy, uninterested, unable.

Authors:  Warren T Blume
Journal:  Epilepsy Curr       Date:  2009 May-Jun       Impact factor: 7.500

2.  Segregation analysis of cryptogenic epilepsy and an empirical test of the validity of the results.

Authors:  R Ottman; W A Hauser; C Barker-Cummings; J H Lee; N Risch
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

3.  The "maternal effect" on epilepsy risk: Analysis of familial epilepsies and reassessment of prior evidence.

Authors:  Colin A Ellis; Samuel F Berkovic; Michael P Epstein; Ruth Ottman
Journal:  Ann Neurol       Date:  2019-11-18       Impact factor: 10.422

Review 4.  Management of epilepsy in women of childbearing age: practical recommendations.

Authors:  Barbara Tettenborn
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 5.  Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy.

Authors:  Jouko I T Isojärvi; Erik Taubøll; Andrew G Herzog
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

6.  Familial risk of epilepsy: a population-based study.

Authors:  Anna L Peljto; Christie Barker-Cummings; Vincent M Vasoli; Cynthia L Leibson; W Allen Hauser; Jeffrey R Buchhalter; Ruth Ottman
Journal:  Brain       Date:  2014-01-26       Impact factor: 13.501

Review 7.  Managing epilepsy in women of childbearing age.

Authors:  Pamela M Crawford
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

8.  Relations of genetic and environmental factors in the etiology of epilepsy.

Authors:  R Ottman; J F Annegers; N Risch; W A Hauser; M Susser
Journal:  Ann Neurol       Date:  1996-04       Impact factor: 10.422

9.  Fertility and Birth Outcomes in Women With Epilepsy Seeking Pregnancy.

Authors:  Page B Pennell; Jacqueline A French; Cynthia L Harden; Anne Davis; Emilia Bagiella; Evie Andreopoulos; Connie Lau; Nichelle Llewellyn; Sarah Barnard; Stephanie Allien
Journal:  JAMA Neurol       Date:  2018-08-01       Impact factor: 18.302

10.  Reproductive decision-making in families containing multiple individuals with epilepsy.

Authors:  Jacquelyn Nakamura; Shawn T Sorge; Melodie R Winawer; Jo C Phelan; Wendy K Chung; Ruth Ottman
Journal:  Epilepsia       Date:  2021-04-04       Impact factor: 5.864

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.